Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy
Few data are available on the efficacy and safety of splenectomy in patients with transfusion-dependent Beta-Thalassemia Major (β-TM) and on its impact on a patient’s health-related quality of life (HRQoL). We examined the long-term HRQoL of adult patients with β-TM in comparison with those treated...
Main Authors: | Giovanni Caocci, Olga Mulas, Susanna Barella, Valeria Orecchia, Brunella Mola, Alessandro Costa, Fabio Efficace, Giorgio La Nasa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/7/2547 |
Similar Items
-
Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review
by: Olga Mulas, et al.
Published: (2022-02-01) -
Anaesthetic management of a patient with Eisenmenger syndrome and β-thalassemia major for splenectomy
by: Nishkarsh Gupta, et al.
Published: (2011-01-01) -
The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major
by: Ayşegül Uğur Kurtoğllu, et al.
Published: (2018-12-01) -
Splenectomy: Does it help in Patients with Thalassemia Major
by: Abdul Salam Memon, et al.
Published: (2017-03-01) -
Laparoscopic splenectomy in patients of β thalassemia: Our experience
by: Patle Nirmal, et al.
Published: (2010-01-01)